About Convergence Pharmaceuticals

What does Convergence Pharmaceuticals do?

Convergence Pharmaceuticals is a provider of novel analgesics for the treatment of chronic pain. An independent biotechnology company focused on developing therapies with potentially commercially attractive efficacy, responder-rate, and side effect profiles. Formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (GSK).

Who are Convergence Pharmaceuticals's competitors?

Convergence Pharmaceuticals's competitors and similar companies include CanniMed, Addex Therapeutics, Hypnion, Athira Pharma, and Anavex Life Sciences.

Where is Convergence Pharmaceuticals headquartered?

Convergence Pharmaceuticals is headquartered in United Kingdom.

How many employees does Convergence Pharmaceuticals have?

Convergence Pharmaceuticals has 1,000 employees 🔒.

When was Convergence Pharmaceuticals founded?

Convergence Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Convergence Pharmaceuticals in?

Convergence Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Convergence Pharmaceuticals

Who are the top strategic acquirers in Convergence Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Convergence Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Convergence Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Convergence Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Convergence Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Convergence Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Convergence Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Convergence Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Convergence Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Convergence Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Convergence Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Convergence Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Convergence Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Convergence Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Convergence Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Convergence Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Convergence Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Convergence Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Convergence Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Convergence Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.